Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy

SA Patel, MB Nilsson, X Le, T Cascone, RK Jain… - Clinical Cancer …, 2023 - AACR
Angiogenesis, the sprouting of new blood vessels from existing vessels, is one of six known
mechanisms employed by solid tumors to recruit blood vessels necessary for their initiation …

Inhibition of vascular endothelial growth factor in the treatment of solid tumors

K Margolin - Current oncology reports, 2002 - Springer
Vascular endothelial growth factor (VEGF) is the term used for a family of tumor-derived
angiogenic factors that mediate endothelial proliferation and vascular permeability …

Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers

NR Smith, D Baker, NH James, K Ratcliffe… - Clinical Cancer …, 2010 - AACR
Purpose: Vascular endothelial growth factor (VEGF) signaling is key to tumor angiogenesis
and is an important target in the development of anticancer drugs. However, VEGF receptor …

VEGF-independent angiogenic factors: beyond VEGF/VEGFR2 signaling

R Eguchi, J Kawabe, I Wakabayashi - Journal of Vascular Research, 2022 - karger.com
Tumors induce angiogenesis to acquire oxygen and nutrition from their adjacent
microenvironment. Tumor angiogenesis has been believed to be induced primarily by the …

[HTML][HTML] Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment

TD Gaddy, Q Wu, AD Arnheim… - PLoS computational …, 2017 - journals.plos.org
Tumors exploit angiogenesis, the formation of new blood vessels from pre-existing
vasculature, in order to obtain nutrients required for continued growth and proliferation …

[HTML][HTML] Exploring the intracrine functions of VEGF-A

S Wiszniak, Q Schwarz - Biomolecules, 2021 - mdpi.com
Vascular endothelial growth factor A (VEGF-A or VEGF) is a highly conserved secreted
signalling protein best known for its roles in vascular development and angiogenesis. Many …

[HTML][HTML] VEGF: a key therapeutic target for the treatment of cancer-insights into its role and pharmacological inhibition

G Tobelem - Targeted Oncology, 2007 - Springer
Angiogenesis, the formation of new blood vessels from existing vessels, is required for tumor
growth, proliferation, and metastasis. Vascular endothelial growth factor (VEGF) is a key …

Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies

G Bocci, S Man, SK Green, G Francia, JML Ebos… - Cancer research, 2004 - AACR
A major obstacle compromising the successful application of many of the new targeted
anticancer drugs, including angiogenesis inhibitors, is the empiricism associated with …

An integrative model for vascular endothelial growth factor A as a tumour biomarker

AM Latham, C Molina-París… - Integrative …, 2010 - academic.oup.com
Vascular endothelial growth factor A (VEGF-A) and its cognate receptors are central to the
regulation of angiogenesis in both physiological and pathological states. In cancer, local …

Complexation of VEGF with bevacizumab decreases VEGF clearance in rats

V Hsei, GG DeGuzman, A Nixon… - Pharmaceutical …, 2002 - search.proquest.com
Angiogenesis plays a critical role in several physiologic and pathologic processes,
particularly in tumor growth, invasion, and metastasis (1). New blood vessels provide tumors …